Menaquinone

DB15381InvestigationalSmall molecule

Menaquinone is under investigation in clinical trial NCT01533441 (Vitamin K2 Intervention in Patients With Vitamin K Antagonists).

Mechanism: Pharmacologically active on Vitamin K-dependent gamma-carboxylase and Vitamin K epoxide reductase complex subunit 1
Curator reviewed
Formula / weight: C₃₆H₄₈O₂ · 512.778 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyHYPYXGZDOYTYDR-HAJWAVTHSA-NSMILESCC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O

Targets

What you can answer from here — as of September 21, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Menaquinone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.